2023 International Congress » Parkinsonism, Others

Meeting: 2023 International Congress

Alterations of gait as an early marker of incipient alpha-synucleinopathy

K-L. Weiß, S. Röttgen, A. Ophey, G. Fink, M. Sommerauer (Cologne, Germany)

Analysis of the network of genes related to Parkinson’s and identification of key proteins

H. Ghapani, D. Morshedi, S. Parsafar, F. Aliakbari (Tehran, Islamic Republic of Iran)

Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.

E. Basha, E. Ranxha, J. Tana (Tirana, Albania)

Atypical parkinsonism and psychiatric disorder in hereditary diffuse leukoencephalopathy with spheroids: a novel variant in the CSF1R gene

M. Gea, B. Flores-Pina, D. Vilas-Rolan, A. Castillo-Gandia, C. Carrato-Moñino, K. Beyer, M. Paré-Curell, A. Massuet, L. Ispierto-González (Badalona, Spain)

Autoimmune encephalitis due to antiglycine antibodies presenting as corticobasal syndrome

S. Secades (Madrid, Spain)

Can optical coherence tomography differentiate Parkinson’s disease from drug-induced parkinsonism?

SY. Kang, W. Suh, SU. Baek, JS. Oh, SY. Seo, JS. Kim, YM. Han, MS. Kim (Hwaseong, Republic of Korea)

Case report- Cavernoma involving substantia nigra and nigrostriatal pathway as a rare cause of secondary parkinsonism with a 3 year follow up

S. Sathyanarayana, J. Pasquini, D. Ledingham, D. Mitra, N. Warren, N. Pavese (Newcastle Upon Tyne, United Kingdom)

Clinical and radiological characteristics of elder patients of Parkinson’s disease with the onset age of more than 80 years old

M. Nomoto, H. Iwaki, R. Nonaka, N. Yano (Imabari, Ehime, Japan)

Clinical, radiological and genetic spectrum of fifteen cases of PLA2G6-Associated Neurodegeneration – A Single Centre Cohort from India

P. Pal, V. Holla, N. Sriram, R. Kumari, P. Phulpagar, S. Kamath, S. Prasad, N. Kamble, J. Saini, R. Mahale, M. Netravathi, H. Padmanabha, V. Gowda, R. Battu, A. Pandey, R. Yadav, B. Muthusamy (Bengaluru, India)

Comparison of biospecimens for α-synuclein seed amplification assays in Parkinson’s disease: A Systematic Review and Network Meta-Analysis

SM. Li, YC. Zheng, C. Yang, ZW. Yu, Y. Jiang, T. Feng (Beijing, China)

DaT Scan Positive Parkinson’s Disease in a Patient with Anti-MuSK Positive Myasthenia Gravis

G. Andraos, N. Ahmed, V. Veerappan (Greer, USA)

DaT-Scans Have Limited Utility in Predicting Treatment Response to Ventriculoperitoneal Shunts in Normal Pressure Hydrocephalus

J. Ma, M. Hamed, D. Victor, T. Kay, M. Salgado (Brooklyn, USA)

Delayed Diagnosis of Hyperthyroidism in Parkinson’s Disease Patient: A Case Report

MH. Utami, A. Tiksnadi, D. Tunjungsari (Jakarta, Indonesia)

Disease progression of data-driven subtypes of Parkinson Disease (PD): 5-year longitudinal study from The Early Parkinson’s disease Longitudinal Singapore (PALS) cohort

X. Deng, ES. Saffari, SN. Ng, NC. Chia, XY. Choi, D. Heng, XB. Xiao, Z. Xu, K. Tay, W. Au, N. Liu, EK. Tan, LT. Tan (Singapore, Singapore)

Early cortical atrophy is related to depression in Parkinson’s disease

E. Backman, L. Saari, R. Parkkola, J. Lötjönen, M. Gardberg, V. Kaasinen (Turku, Finland)

Early-onset levodopa-responsive Parkinsonism associated with dysarthria, pyramidalism, and dystonia: a rare condition that can benefit from a combined treatment approach.

L. Gallo, M. Avenali, P. Mitrotti, C. Tassorelli, R. Zangaglia, F. Valentino, S. Gana, EM. Valente, C. Pacchetti, G. Cosentino (Pavia, Italy)

Effect of Best Practice Advisory on the administration of contraindicated medications to hospitalized patients with Parkinson’s disease and related disorders

N. Chunga, K. Amodeo, M. Braun, B. Valdovinos, I. Richard (Rochester, USA)

Empowerment of People with Parkinson`s disease: development, testing and evaluation of a cross-sectoral, intervention-based self-management program

T. Thomsen, S. Skovbølling, M. Møller, V. Grønlund, M. Brønden, B. Biering-Sørensen (Glostrup, Denmark)

Feasibility, Reliability and Value of Remote Levodopa Challenge Test in Parkinson’s Disease

Z. Zeng, W. Shi, X. Wan, Z. Lin, Z. Chen, C. Zhang (Shanghai, China)

Gait during turning associates with imbalance and falls in PD: 3D Video based analysis from a single camera

JH. Shin, HY. Jeon, B. Jin, SM. Lee, KA. Woo, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

Glial neurotrophiz factor as a differential marker of Parkinson`s disease and vascular parkinsonism

R. Matmurodov, E. Abduqodirov, R. Juraev, O. Naimov, B. Muminov, K. Khalimova, H. Daminova (Tashkent, Uzbekistan)

Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM)

M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez (Madrid, Spain)

Hydrocephalus associated with Chiari-I malformation presenting with parkinsonism and dystonia

A. Maheshwary, L. Wolansky, B. Rodrigues, K. Bulsara, D. Karimeddini, B. Springate, N. Prakash (Hartford, USA)

Kufor-Rakef syndrome, report of two unrelated cases from Chile studied with DAT-PET

P. Saffie, E. Fernandez, S. Mariacca, P. Salles, P. Chana (Santiago, Chile)

Machine learning classifies Parkinson’s Disease and Progressive Supranuclear Palsy on saccade, pupil, and blink measures during a naturalistic free-viewing task

D. Brien, H. Riek, R. Yep, J. Huang, B. Coe, B. White, M. Habibi, D. Grimes, M. Jog, A. Lang, C. Marras, M. Masellis, P. Mclaughlin, A. Peltsch, A. Roberts, B. Tan, D. Beaton, W. Lou, E. Finger, A. Frank, D. Tang-Wai, C. Tartaglia, S. Black, R. Swartz, W. Oertel, D. Munoz (Kingston, Canada)

Machine Learning Prediction of Gait Dysfunction from DTI Multi-Spectral Diffusion Weighted Imaging ROIs

C. Raimondo, I. Ailes, I. Shelley, K. Shivok, M. Syed, M. Alizadeh (Philadelphia, USA)

Machine Learning Prediction of Motor Score Reduction following DBS Surgery in PD

C. Raimondo, C. Wu, M. Alizadeh (Philadelphia, USA)

May CSF biomarkers have a role in degenerative parkinsonian syndromes workup?

C. Bernardes, JM. Alves, I. Cunha, D. Carneiro, J. Lemos, F. Moreira, MJ. Leitão, I. Baldeiras, I. Santana, A. Morgadinho (Coimbra, Portugal)

Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort

S. Weber, M. Dakna, A. Bednorz, M. Bartl, E. Lang, T. Wicke, M. Starke, J. Ebentheuer, F. Sixel-Döring, M. Muntean, S. Schade, C. Trenkwalder, B. Mollenhauer (Goettingen, Germany)

Movement disorders in osmotic demyelination syndrome: A case series from a tertiary care centre

A. Panjwani, A. Kumar, A. Ranjan (Patna, India)

Oculomotor parameters measured during free viewing of video differentiate Parkinson’s disease from progressive supranuclear palsy

H. Riek, B. White, D. Brien, B. Coe, C. Fearon, S. Arnott, D. Beaton, M. Binns, S. Black, E. Finger, A. Frank, D. Grimes, A. Lang, W. Lou, C. Marras, M. Masellis, P. Mclaughlin, J. Orange, A. Peltsch, A. Roberts, T. Steeves, K. Sunderland, B. Tan, D. Tang-Wai, C. Tartaglia, D. Munoz (Kingston, Canada)

Opicapone’s Effects on Progression Scales in Relation to the 9-Symptom Wearing-off Questionnaire: the OPTIPARK Study

D. Martins, A. Lees, H. Reichmann, J-F. Rocha (Coronado, Portugal)

Parkinson’s Disease Hospital Optimization Project

B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)

Parkinsonism and dilated ventricles: not all hydrocephalus is normal-pressure

D. Tang, J. Vijayan, CH. Tan, SF. Woo, JH. Tan (Singapore, Singapore)

Parkinsonism in sjogren disease

G. Wechtati, H. Derbali, I. Bedoui, M. Yedaes, M. Messelmani, M. Mansour, J. Zaouali, R. Mrissa (Ben Arous, Tunisia)

Post-Covid parkinsonism: a systematic review of clinical presentations

P. Polverino, S. Lalli, M. Lo Giudice, A. Albanese (Rozzano, Italy)

Potential role of Alpha-synuclein levels in Platelets in GBA-related PD

G. Uras, S. Lucas, A. Schapira (London, United Kingdom)

Prediction of freezing of gait in Parkinson’s disease based on wearable sensors

SY. Ouyang, J. Zhao, SD. Chen (Wuhan, China)

Prodromal stage early biomarkers in Parkinson’s disease and parkinsonism in Uzbek nationality

DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)

Rapidly progressive dementia – catatonia – myoclonus in 80 years old patient: An unusual case

DAN. Rebolledo Garcia, ART. Cadena Fernandez, ANA. Michel Chavez, JUA. Calderon Martinez, HOR. Senties Madrid, GRI. Romero Sanchez (Mexico City, Mexico)

Sacral Mass Lesion Mimicking Atypical Foot Dystonia In Parkinsonian Patient

B. Barton (CHICAGO, USA)

Sex-Specific Association Between Plasma Vitamin D and Parkinson’s Disease: A Mendelian Randomization Study

T. Antar, H. Iwaki (Bethesda, USA)

Subacute parkinsonism associated with Zic4 antibodies: a case report

V. Mendes Ferreira, M. Magriço, D. Krupka, B. Meira (Lisboa, Portugal)

Subjective cognitive decline and Frailty in an Asian cohort of patients with Parkinson’s Disease

P. Venugopalan Menon, K. Gai Fui, E. Elda Kamaruddin, L. Sun, CH. Tan, P. Chong, S. Kumar Seetharaman (Singapore, Singapore)

The diagnosis value of dopaminergic responsiveness of Parkinson’s disease： a systematic review and meta-analysis

WY. Kou, HH. Cai, FT. Feng (beijiing, China)

The examination of the relationship between limited thoracic mobility and shoulder joint function in individuals with extrapyramidal syndrome

C. Bouzineki, A. Christakou, S. Kanellopoulou, X. Arabatzi, V. Sakellari (Athens, Greece)

The Roche ‘End-to-End Matrix’ for Patient-Centric Drug Discovery and Development – Focus on Parkinson’s disease

A. Paehler, A. Stepan, E. Mracsko, K. Taylor, B. Zinnhardt, H. Binch, L. Gobbi, T. Luebbers, A. Olivares, R. Rodriguez Sarmiento, U. Grether, S. Dudal, G. Pagano (Basel, Switzerland)

To stimulate or not to stimulate? Bilateral subthalamic (STN) Deep Brain Stimulation (DBS) in cases of young-onset parkinsonism with mitochondrial dysfunction induced neurodegeneration.

E. Efthymiou, B. Büchele, S. Mahendran, L. Stieglitz, C. Baumann, B. Balint (zurich, Switzerland)